Biohaven Pharmaceutical Holding Company Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 8.41 M | $314.27 M | 8.07% | 8.92% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.67 M | $286.37 M | 11.48% | 8.12% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 6.98 M | $260.73 M | 12.14% | 7.40% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 6.56 M | $244.99 M | 0.77% | 6.95% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 5.62 M | $209.92 M | 8.10% | 5.96% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.43 M | $165.39 M | 21.57% | 4.69% |
| STATE STREET CORP | 02/14/2025 | 3.51 M | $131.19 M | 7.86% | 3.72% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.41 M | $127.45 M | -0.77% | 3.62% |
| RP MANAGEMENT, LLC | 02/03/2025 | 2.94 M | $146.74 M | 0.00% | 3.11% |
| FMR LLC | 02/13/2025 | 2.11 M | $78.97 M | 14.84% | 2.24% |
| BELLEVUE GROUP AG | 02/14/2025 | 2.04 M | $76.23 M | 0.00% | 2.16% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.98 M | $73.92 M | 144.51% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.91 M | $71.18 M | 11.13% | 2.02% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 1.67 M | $62.46 M | 39.42% | 1.77% |
| HOLOCENE ADVISORS, LP | 02/14/2025 | 1.09 M | $40.67 M | 27.70% | 1.15% |
| ARS INVESTMENT PARTNERS, LLC | 01/16/2025 | 1.04 M | $38.87 M | 1.02% | 1.10% |
| BROWN ADVISORY INC | 02/14/2025 | 975,585 | $36.44 M | 0.75% | 1.03% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 922,965 | $34.47 M | -38.48% | 0.98% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 919,235 | $34.33 M | 55.12% | 0.97% |
| REDMILE GROUP, LLC | 02/14/2025 | 904,496 | $33.78 M | -12.54% | 0.96% |
| NORGES BANK | 02/12/2025 | 902,565 | $33.71 M | 100.00% | 0.96% |
| ORACLE INVESTMENT MANAGEMENT INC | 02/14/2025 | 851,770 | $31.81 M | 20.78% | 0.90% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 816,823 | $30.51 M | 27.16% | 0.87% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 783,672 | $29.27 M | -13.20% | 0.83% |
| UBS GROUP AG | 02/14/2025 | 747,720 | $27.93 M | 492.98% | 0.79% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 713,587 | $26.65 M | -0.84% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 701,314 | $26.19 M | 10.85% | 0.74% |
| CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 671,414 | $25.08 M | 0.00% | 0.71% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 634,055 | $23.68 M | 160.75% | 0.67% |
| WOODLINE PARTNERS LP | 02/14/2025 | 601,922 | $22.48 M | -34.84% | 0.64% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 575,000 | $21.48 M | -61.21% | 0.61% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 560,056 | $20.92 M | 40.07% | 0.59% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 558,761 | $20.87 M | 9.46% | 0.59% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 548,575 | $20.49 M | 7.86% | 0.58% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 521,099 | $19.46 M | 8.73% | 0.55% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 508,682 | $18.99 M | 40.00% | 0.54% |
| PFIZER INC | 02/14/2025 | 505,645 | $18.89 M | 100.00% | 0.54% |
| 5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 478,972 | $17.89 M | 0.00% | 0.51% |
| PFM HEALTH SCIENCES, LP | 02/14/2025 | 431,916 | $16.13 M | 100.00% | 0.46% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 405,848 | $15.16 M | 32.17% | 0.43% |
| BARCLAYS PLC | 02/13/2025 | 392,727 | $14.67 M | 46.50% | 0.42% |
| MARSHALL WACE, LLP | 02/13/2025 | 366,891 | $13.70 M | -1.29% | 0.39% |
| BOONE CAPITAL MANAGEMENT LLC | 02/14/2025 | 361,420 | $13.50 M | 100.00% | 0.38% |
| EMERALD ADVISERS, LLC | 02/11/2025 | 360,538 | $13.47 M | 100.00% | 0.38% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 357,765 | $13.36 M | -1.61% | 0.38% |
| BISON WEALTH, LLC | 02/14/2025 | 332,428 | $12.42 M | 0.44% | 0.35% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 321,866 | $12.02 M | 3.55% | 0.34% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 295,078 | $11.02 M | 9.14% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 282,300 | $10.54 M | 2.36% | 0.30% |
| FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 262,442 | $9.80 M | -16.90% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biohaven Pharmaceutical Holding Company Ltd. institutional Ownership - FAQ's
During the previous two years, 334 institutional investors and hedge funds held shares of Biohaven Pharmaceutical Holding Company Ltd.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 8.41 M
BlackRock Funding, Inc. /DE: 7.67 M
JANUS HENDERSON GROUP PLC: 6.98 M
STIFEL FINANCIAL CORP: 6.56 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 5.62 M
FARALLON CAPITAL MANAGEMENT LLC: 4.43 M
97.78% of Biohaven Pharmaceutical Holding Company Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 105.00 M shares in the last 24 months. This purchase volume represents approximately $4.08 B in transactions.